Purchase Order 75D30124P18936
Award Date 6/15/24
Potential Completion Date 1/30/26
Potential Value $67K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a $20,591.00 firm fixed-price purchase order to Proteos Inc. for custom protein purification and expression services. The contract has an ultimate completion date of April 17, 2015. Proteos Inc. is a for-profit organization that specializes in producing high-quality recombinant proteins, particularly HIV-related proteins, for federal agencies like the Centers for Disease...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Proteos Inc., a small business contractor. The contract is for the custom expression and purification of an HIV protein called OTSB, with a ceiling value of $11,069.00. Proteos Inc. has demonstrated expertise in producing high-quality recombinant proteins, particularly HIV-related proteins, which are crucial for research...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Proteos Inc. for the expression and purification of proteins up to 5 liters. The contract has a ceiling value of $20,591.00 and a period of performance ending on January 15, 2015. Proteos Inc. is a for-profit organization that specializes in the production of recombinant proteins, particularly those related...
- The Centers for Disease Control and Prevention (CDC) awarded a sole-source, firm-fixed-price purchase order to Roche Diagnostics Corporation to provide biomedical reagents, testing supplies, and commodities required to conduct HIV molecular laboratory testing. The $25,725.24 contract has an ultimate completion date of October 17, 2029. The requirement is not set aside, as Roche Diagnostics is identified as the only vendor capable of providing the proprietary reagents and supplies compatible with...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Life Technologies Corporation, a for-profit organization, for $105,600.00 to provide HIV-1 Genotyping Kits including Amplification Modules and Cycle Sequencing Modules. This sole source award, with no set-aside, was made on September 6, 2018, with a completion date of August 31, 2019. Life Technologies Corporation is a provider of tools and technologies for...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Preomics Inc., a foreign-owned, self-certified small disadvantaged business, to procure the PreOmics PreON proteomics liquid handling system for automated sample preparation. This $104,000 sole-source contract was awarded under the authority of Federal Acquisition Regulation (FAR) 13.106-1(b) and 10 U.S.C. 2304(c)(1). The CDC's Biomedical and Chemical...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $91,758.84 firm fixed-price purchase order is for the delivery of HIV test kits and supplies. The contract does not have a set-aside designation and has an ultimate completion date of December 31, 2021. Life Technologies Corporation, as the prime contractor, is a leading provider of biomedical research and genetic...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $284,847.50 firm fixed-price purchase order to Protein Metrics, LLC on September 1, 2023, with an ultimate completion date of August 31, 2028. This contract, which carries no set-aside designation, procures software licenses and protein analytics services from the vendor, a specialized provider of vendor-neutral software for mass spectrometry-based protein analysis. Protein Metrics' solutions enable advanced analytical...
- This is a $54,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to MS Bioworks LLC, a for-profit limited liability company that provides protein mass spectrometry and proteomics services. The contract, identified as MS BIOWORKS MSB-DIA-03, is for an ultimate completion date of July 30, 2024. Based on the vendor's past federal contract awards, the services to be provided under this contract likely include quantitative proteomics analysis,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Promega Corporation for $142,450.00 to provide laboratory supplies. The contract, which does not have a set-aside designation, will run through September 30, 2017. Promega, a global life sciences company that manufactures and markets integrated systems and reagents for biological research and molecular diagnostics, has previously provided DNA analysis equipment,...
The Centers for Disease Control and Prevention (CDC) awarded a sole-source, firm fixed-price purchase order to Proteos Inc., a for-profit organization, to provide pilot-scale preparation of HIV-1 p24-gp41 and HIV-2 p24_env gp41 proteins. This contract, valued at $67,380.00, has an ultimate completion date of January 30, 2026. The contract was awarded on June 15, 2024, and does not have a set-aside designation. Proteos Inc. was selected as the sole source for this requirement due to its unique capability to produce the high-quality recombinant proteins in the demanded quantity, which is essential for quality assurance and reproducibility in research. This contract supports the CDC's public health initiatives and research related to HIV.
Generated 7/31/25, 11:06 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Proteos Laboratory Reagents & Supplies | 75D301-24-Q-77714 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Solicitation 1/1 | 4/29/24, 11:13 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 7/30/25 | |
| Not listed | Not listed | $67.4k | 6/11/24 |